Diagnostica Stago: partner of biological and biomedical world

COMPANY PROFILE

COMPANY PROFILE

With a staff close to 1,500 and the most advanced technologies, Diagnostica Stago formulates, manufactures and markets worldwide, the broadest range of reagents and analytical instruments in haemostasis. Diagnostica Stago devotes its research and innovative skills to the development of increasingly effective medical diagnostic products and instrumentation.

Because we are committed to a better understanding of haemostasis and thrombosis, Diagnostica Stago's creativity, supported by a team of specialized researchers, results in a range of reagents and instruments which just keeps getting better. This involves constant leading-edge research as well as the improvement of existing kits.

Selected distributors and international marketing support
Thanks to a wide international network of distributors, Diagnostica Stago is represented in more than 110 countries. Without exception, each distributor is chosen according to strict criteria regarding the performance of its team, its capabilities in after-sales services, and its commitment to knowing and promoting the Diagnostica Stago line. For the last few years, our efforts have focused primarily on the individual needs of each country and each market, taking into account their specific expectations. This is effective because of the local field activity of the sales and marketing export team.

Flexible production
Faced with a diverse and ever-increasing demand, Diagnostica Stago is finding ways of closely monitoring the evolution of markets and forecasting their development. The flexibility of our production capabilities and the proficiency of our logistics division have enabled us to respond effectively to the needs of our partners and international clients.

Your partner for the diagnosis of coagulation and thrombosis
For a long time, Diagnostica Stago has maintained a partnership with many hospital and research laboratories working on thromboembolic diseases, and blood transfusion centres. Diagnostica Stago products have a clinical application in diagnosis, in the treatment of haemostasis disorders (haemophilia, thrombosis) and in the prediction of thromboembolic risk. By the way, the assessment of thrombosis which represents one of the priorities of Diagnostica Stago is considered by the experts as the future of haemostasis.

Diagnostica Stago Gennevilliers (France) Reagent and Instrumentation R&D Center
Diagnostica Stago Gennevilliers (France) Instrumentation Manufacturing Plant
Diagnostica Stago Taverny (France) Reagents Manufacturing Plant
Diagnostica Stago Asnières sur Seine (France) Headquarters
Diagnostica Stago Franconville (France) International training center
Diagnostica Stago Parsippany (NJ - USA) American subsidiary
Stago Diagnosis Beijing (China) Chinese subsidiary
Diagnostica Stago Reading (England) U.K. subsidiary

Key date of STAGO's development

1945: Creation of Laboratoire Stago, Paris, France
1962: Stago develops its first test reagents for coagulation
1976: Stago dedicates itself exclusively to coagulation testing and becomes Diagnostica Stago
1979: Creation of the Reagent Research and Development Centre
1985: Establishment of an American subsidiary
1987: Creation of the Instrumentation Division
1992: Worldwide launch of STA^®, the first fully automated coagulation analyser
2000: Addition of a new production facility in Taverny (France)
2003: Establishment of a Chinese subsidiary
2005: Establishment of an United Kingdom subsidiary
2008: Establishment of an AUE (Dubaï), an Australia/New Zealand and a Canada subsidiaries


Diagnostica Stago markets shares	The turnover of Diagnostica Stago

Click on the logo to reach the web site